Immunosuppressive Agents: all 5,940 studies that test it

Page 14 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.

• CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1CompletedNCT01773707Phase 2Results posted
• Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy VolunteersCompletedNCT01766050Phase 4Results posted
• Sirolimus in Kidney Transplant Patients With Squamous Cell Skin CarcinomaTerminatedNCT01764607Phase 2Results posted
• Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic MalignanciesCompletedNCT01760655Phase 2Results posted
• Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON)TerminatedNCT01757691Phase 2Results posted
• Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell TransplantCompletedNCT01754389Phase 2Results posted
• Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast CancerCompletedNCT01750073Phase 2Results posted
• Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow TransplantationTerminatedNCT01749293Phase 2Results posted
• Co-Administration Of Methotrexate And CP-690,550CompletedNCT01745055Phase 1Results posted
• An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker AnalysisCompletedNCT01743560Phase 4Results posted
• Abatacept as GVHD Prophylaxis Phase 2CompletedNCT01743131Phase 2Results posted
• CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant MelanomaTerminatedNCT01740401Phase 2Results posted
• Exposure Study Comparing 3 Routes of Methotrexate (MTX) AdministrationCompletedNCT01737944Phase 1/2Results posted
• Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung CancerCompletedNCT01737502Phase 1/2Results posted
• PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in ChildrenCompletedNCT01734512Phase 2Results posted
• Belatacept Early Steroid Withdrawal TrialCompletedNCT01729494Phase 4Results posted
• Velcade + Cyclophosphamide in Newly Diagnosed Multiple MyelomaTerminatedNCT01729338Phase 2Results posted
• Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus LenalidomideCompletedNCT01723839Phase 2Results posted
• Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)TerminatedNCT01716039Phase 2Results posted
• A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid ArthritisCompletedNCT01715896Phase 2Results posted
• Efficacy and Safety Study of Abatacept to Treat Lupus NephritisTerminatedNCT01714817Phase 3Results posted
• A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset SeizuresCompletedNCT01713946Phase 3Results posted
• A Study in Participants With Moderate to Severe Rheumatoid ArthritisCompletedNCT01711359Phase 3Results posted
• Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus ToxicityTerminatedNCT01709136Phase 2/3Results posted
• Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01707004Phase 2Results posted
• Belimumab Assessment of Safety in SLECompletedNCT01705977Phase 4Results posted
• A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya®CompletedNCT01705236Phase 4Results posted
• Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast CancerCompletedNCT01698918Phase 2Results posted
• Cimzia Versus Mesalamine for Crohn's RecurrenceTerminatedNCT01696942Phase 4Results posted
• A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate CancerCompletedNCT01696877Phase 1/2Results posted
• Early Treatment for Acute ACL TearCompletedNCT01692756Phase 2Results posted
• 1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUXTerminatedNCT01692626Phase 2Results posted
• Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque PsoriasisCompletedNCT01690299Phase 3Results posted
• Busulfan and Cyclophosphamide Followed By ALLO BMTTerminatedNCT01685411Not applicableResults posted
• Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate SodiumCompletedNCT01680861Phase 3Results posted
• Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine TumorsCompletedNCT01678664Phase 2Results posted
• Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural MesotheliomaCompletedNCT01675765Phase 1Results posted
• S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerActive, not recruitingNCT01674140Phase 3Results posted
• Dose Dense TC + Pegfilgrastim Support for Breast CancerCompletedNCT01671319Phase 2Results posted
• Belimumab for the Treatment of Diffuse Cutaneous Systemic SclerosisCompletedNCT01670565Phase 2Results posted
• Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCaCompletedNCT01670500Phase 2Results posted
• The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)CompletedNCT01668004Phase 4Results posted
• Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney TransplantCompletedNCT01666951Phase 2Results posted
• CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid MalignanciesCompletedNCT01664910Phase 1/2Results posted
• Belimumab in Remission of VASculitisCompletedNCT01663623Phase 3Results posted
• SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath TumorsCompletedNCT01661283Phase 2Results posted
• A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate DosageTerminatedNCT01661140Phase 4Results posted
• Pharmacogenetic Trial of Tacrolimus After Pediatric TransplantationCompletedNCT01655563Phase 2Results posted
• Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive RegimensCompletedNCT01653847Not applicableResults posted
• Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal InjectionCompletedNCT01652495Phase 4Results posted
• Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant RecipientsCompletedNCT01650545Phase 1/2Results posted
• A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell LymphomaCompletedNCT01649856Phase 3Results posted
• Pediatric Lupus Trial of Belimumab Plus Background Standard TherapyCompletedNCT01649765Phase 2Results posted
• Using mTOR Inhibitors in the Prevention of BK NephropathyCompletedNCT01649609Not applicableResults posted
• Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant RecipientsCompletedNCT01649427Phase 4Results posted
• A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate TherapyCompletedNCT01645280Phase 2Results posted
• Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)CompletedNCT01642186Phase 2Results posted
• Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell TransplantTerminatedNCT01640301Phase 1/2Results posted
• Efficacy and Safety of Belimumab in Patients With Active Lupus NephritisCompletedNCT01639339Phase 3Results posted
• A Study to Continue ASP015K Treatment to Rheumatoid Arthritis Patients Who Completed Phase IIb Study or Phase III Study of ASP015KCompletedNCT01638013Phase 3Results posted
• Everolimus in Treating Cutaneous T-cell LymphomaTerminatedNCT01637090Phase 2Results posted
• The Everolimus-Transplant Exit Strategy Trial (E-TEST)TerminatedNCT01636466Phase 3Results posted
• MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus CopaxoneTerminatedNCT01633112Phase 3Results posted
• Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)CompletedNCT01632241Phase 4Results posted
• Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple MyelomaCompletedNCT01632150Phase 2Results posted
• Exemestane-RAD001-MetforminTerminatedNCT01627067Phase 2Results posted
• Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal DisordersCompletedNCT01626092Not applicableResults posted
• A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant RecipientsCompletedNCT01625377Phase 3Results posted
• Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.CompletedNCT01625182Phase 3Results posted
• Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant RecipientsCompletedNCT01624948Phase 4Results posted
• Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.CompletedNCT01623596Phase 4Results posted
• T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic TransplantTerminatedNCT01621477Phase 2Results posted
• Comparison of Methotrexate (MTX) and the VIBEX™ MTX DeviceCompletedNCT01618968Phase 2Results posted
• A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins LymphomaCompletedNCT01614197Phase 1Results posted
• A Study of Belimumab in Idiopathic Membranous GlomerulonephropathyCompletedNCT01610492Phase 2Results posted
• Finding the Optimum Regimen for Duchenne Muscular DystrophyCompletedNCT01603407Phase 3Results posted
• Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes MellitusTerminatedNCT01603121Phase 1/2Results posted
• Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + CorticosteroidsCompletedNCT01601821Phase 4Results posted
• BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115CompletedNCT01597622Phase 3Results posted
• A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT01597492Phase 4Results posted
• Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)CompletedNCT01596062Phase 2Results posted
• An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1)CompletedNCT01595009Phase 4Results posted
• Cardiovascular Inflammation Reduction TrialCompletedNCT01594333Phase 3Results posted
• A Study of RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to MethotrexateCompletedNCT01587989Phase 3Results posted
• STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)CompletedNCT01585298Phase 4Results posted
• Study of Belimumab Administered Subcutaneously to Healthy SubjectsCompletedNCT01583530Phase 1Results posted
• Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic CancerCompletedNCT01582191Phase 1Results posted
• Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib TosylateTerminatedNCT01582009Phase 1/2Results posted
• Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck CancerCompletedNCT01581970Phase 2Results posted
• Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to ScreeningCompletedNCT01578850Phase 4Results posted
• A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720CompletedNCT01578330Phase 4Results posted
• Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine ConditioningCompletedNCT01572662Phase 2Results posted
• Crohn's Allogeneic Transplant StudyTerminatedNCT01570348Phase 2Results posted
• Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl FumarateCompletedNCT01568112Phase 3Results posted
• 3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA TrialCompletedNCT01563354Phase 2Results posted
• Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor MalignanciesCompletedNCT01554371Phase 1/2Results posted
• Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant RecipientsCompletedNCT01551212Phase 4Results posted
• Pediatric Arthritis Study of Certolizumab PegolCompletedNCT01550003Phase 3Results posted
• Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant RecipientsCompletedNCT01544491Phase 3Results posted
• Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to AdalimumabTerminatedNCT01543204Phase 4Results posted

← Immunosuppressive Agents overview